Biochemistry 38, 1055910566
122 MiyazawaT.MatsumotoK.OhmichiH.KatohH.YamashimaT.NakamuraT
They accomplish this by binding to specific receptors on cell surfaces and activating biological pathways that stimulate tissue repair, reduce inflammation, and improve circulation to injured areas
The notable peptide vaccines that have undergone phase I/II/III clinical trials include HER-2/neu immunodominant peptide (lung, breast, or ovarian cancer) [6971], Mucin-1 (MUC-1, Stimuvax), peptide (breast or colon cancer) [72, 73], Carcinoembryonic antigen (colorectal, gastric, breast, pancreatic and non-small-cell lung cancers) [74, 75], Prostate-specific membrane antigen (prostate cancer) [7678], HPV-16 E7 peptide (cervical cancer) [79], Ras oncoprotein peptide (colorectal and pancreatic carcinomas) [8082], and Melanoma antigens (Melanoma) [62, 68, 8385]
And she was like, whoa
Related questions References References (10) 1 Pernicious Anemia: The Hematological Presentation of a Multifaceted Disorder Caused by Cobalamin Deficiency
